AAPL 195.34 -0.22 (-0.11%)MSFT 120.03 +1.13 (+0.95%)FB 166.05 +1.09 (+0.66%)ZNGA 5.42 -0.04 (-0.64%)NVDA 183.89 +1.36 (+0.75%)WBA 63.57 -0.19 (-0.30%)GOOG 1231.1 +7.88 (+0.64%)PIH 5.45 -0.16 (-2.85%)
AAPL 195.34 -0.22 (-0.11%)MSFT 120.03 +1.13 (+0.95%)FB 166.05 +1.09 (+0.66%)ZNGA 5.42 -0.04 (-0.64%)NVDA 183.89 +1.36 (+0.75%)WBA 63.57 -0.19 (-0.30%)GOOG 1231.1 +7.88 (+0.64%)PIH 5.45 -0.16 (-2.85%)

Financial Summary PTLA Quote Portola Pha

Portola Pharmaceuticals Inc. Quote

Portola Pharmac (PTLA)

33.63 0.36 Healthcare
Stock Performance rating :
Recommendation :
Strong Sell
Score :
C+
Symbol PTLA
Price 33.63
Beta 1.51
Vol Avg 1.64 M
Mkt cap 2.00 B
Shares 66
Last Div Not Available
Div Yield 0.00%
DCF Unlevered -573.63 Strong Sell
DCF Levered -532.91 Strong Sell
ROE -135.92% Strong Sell
ROA -78.74% Strong Sell
Operating Margin -862.50% Strong Sell
Debt/Equity 338.64% Strong Buy
P/E -6.34 Strong Sell
P/B 25.22 Strong Buy
Company Profile

CEO

William Lis

Sector

Healthcare

Industry

Biotechnology

Exchange

Nasdaq Global Select

Description

Portola Pharmaceuticals Inc is engaged in the healthcare sector. It develops & commercializes novel therapeutics to combat thrombosis, hematologic disorders & inflammation.